Wound Care (Pharmacies) - Eastern Europe

  • Eastern Europe
  • Revenue in the Wound Care market is projected to reach US$90.19m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.35%, resulting in a market volume of US$91.78m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$1,042.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.38 are generated in 2024.

Key regions: China, South Korea, Japan, Canada, India

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Wound Care (Pharmacies) market in Eastern Europe is experiencing significant growth and development. Customer preferences in the region are shifting towards more advanced wound care products and treatments. This can be attributed to several factors, including an aging population, an increase in chronic diseases, and a growing awareness of the importance of proper wound care. Customers are seeking products that are effective, easy to use, and provide quick healing. They are also looking for products that are affordable and easily accessible, which is why pharmacies play a crucial role in the distribution of wound care products in Eastern Europe. One of the key trends in the market is the rising demand for advanced wound dressings. These dressings offer several advantages over traditional dressings, such as better moisture management, improved healing rates, and reduced risk of infection. Customers are increasingly opting for these advanced dressings, which are available in a variety of forms, including hydrocolloids, foams, and films. The demand for these products is expected to continue growing as customers become more aware of their benefits. Another trend in the market is the increasing adoption of wound care devices. These devices, such as negative pressure wound therapy systems and electrical stimulation devices, are used to accelerate wound healing and improve patient outcomes. Customers are recognizing the value of these devices and are willing to invest in them to enhance the healing process. This trend is likely to continue as healthcare providers and patients become more familiar with the benefits of these devices. Local special circumstances in Eastern Europe also contribute to the development of the Wound Care (Pharmacies) market. For example, the region has a high prevalence of chronic diseases, such as diabetes and cardiovascular diseases, which can lead to the development of chronic wounds. As a result, there is a growing need for effective wound care products and treatments. Additionally, the region has a well-established healthcare infrastructure, with a large number of pharmacies that serve as a convenient and accessible source for wound care products. Underlying macroeconomic factors also play a role in the development of the market. Eastern Europe has been experiencing economic growth, which has led to an increase in disposable income and healthcare spending. As a result, customers are more willing to invest in high-quality wound care products and treatments. Furthermore, the region has a favorable regulatory environment that supports the growth of the healthcare sector, including the wound care market. In conclusion, the Wound Care (Pharmacies) market in Eastern Europe is developing due to changing customer preferences, including a shift towards advanced wound care products and treatments. The market is also driven by local special circumstances, such as a high prevalence of chronic diseases and a well-established healthcare infrastructure. Underlying macroeconomic factors, including economic growth and a favorable regulatory environment, further contribute to the market's development.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)